Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
31
PACS Quote, Financials, Valuation and Earnings
Last price:
$12.32
Seasonality move
:
36.65%
Day range:
$12.03 - $12.47
52-week range:
$8.28 - $43.92
Dividend yield:
0%
P/E ratio:
20.01x
P/S ratio:
0.54x
P/B ratio:
3.35x
Volume:
768.9K
Avg. volume:
681.3K
1-year change:
-62.37%
Market cap:
$1.9B
Revenue:
$3.1B
EPS (TTM):
$0.65
Analysts' Opinion
-
Consensus RatingPACS Group has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $30.50, PACS Group has an estimated upside of 146.96% from its current price of $12.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $12.35.
Fair Value
-
According to the consensus of 3 analysts, PACS Group has 146.96% upside to fair value with a price target of $30.50 per share.
PACS vs. S&P 500
-
Over the past 5 trading days, PACS Group has underperformed the S&P 500 by -3.88% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PACS Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PACS Group has grown year-over-year revenues for 0 quarters straight. In the most recent quarter PACS Group reported revenues of $981.8M.
Earnings Growth
-
PACS Group has grown year-over-year earnings for 0 quarters straight. In the most recent quarter PACS Group reported earnings per share of -$0.07.
Enterprise value:
2.3B
EV / Invested capital:
--
Price / LTM sales:
0.54x
EV / EBIT:
12.20x
EV / Revenue:
0.69x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-19.85x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
10.61x
Gross Profit (TTM):
$531.6M
Return On Assets:
--
Net Income Margin (TTM):
2.87%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
0.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | $3.4B | $760.7M | $981.8M | |
| Gross Profit | -- | -- | $531.6M | $118.4M | $153.9M | |
| Operating Income | -- | -- | $189.5M | $49.5M | $710K | |
| EBITDA | -- | -- | $220.5M | $53.1M | $5.6M | |
| Diluted EPS | -- | -- | $0.65 | $0.14 | -$0.07 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | $800.6M | |
| Total Assets | -- | -- | -- | -- | $3.9B | |
| Current Liabilities | -- | -- | -- | -- | $468.1M | |
| Total Liabilities | -- | -- | -- | -- | $3.3B | |
| Total Equity | -- | -- | -- | -- | $578.2M | |
| Total Debt | -- | -- | -- | -- | $490.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | $151.8M | -$21.1M | $34.8M | |
| Cash From Investing | -- | -- | -$306.9M | -$9.7M | -$121M | |
| Cash From Financing | -- | -- | $96.6M | -$23.5M | $70.7M | |
| Free Cash Flow | -- | -- | -$117.9M | -$32M | -$76.7M | |
PACS
Sector
Market Cap
$1.9B
$34.4M
Price % of 52-Week High
28.12%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
-62.37%
-37.36%
Beta (5-Year)
--
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
79.81%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$12.68
200-day SMA
Sell
Level
$16.94
Bollinger Bands (100)
Buy
Level
9.76 - 12.6
Chaikin Money Flow
Buy
Level
250.8K
20-day SMA
Sell
Level
$12.82
Relative Strength Index (RSI14)
Buy
Level
52.20
ADX Line
Sell
Level
14.26
Williams %R
Neutral
Level
-77.3034
50-day SMA
Buy
Level
$11.33
MACD (12, 26)
Buy
Level
3.44
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Sell
Level
-1.7M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.9161)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (2.928)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Stock Forecast FAQ
In the current month, PACS has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PACS average analyst price target in the past 3 months is $30.50.
-
Where Will PACS Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that PACS Group share price will rise to $30.50 per share over the next 12 months.
-
What Do Analysts Say About PACS Group?
Analysts are divided on their view about PACS Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PACS Group is a Sell and believe this share price will drop from its current level to $18.00.
-
What Is PACS Group's Price Target?
The price target for PACS Group over the next 1-year time period is forecast to be $30.50 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PACS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PACS Group is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PACS?
You can purchase shares of PACS Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PACS Group shares.
-
What Is The PACS Group Share Price Today?
PACS Group was last trading at $12.32 per share. This represents the most recent stock quote for PACS Group. Yesterday, PACS Group closed at $12.35 per share.
-
How To Buy PACS Group Stock Online?
In order to purchase PACS Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
